Merge Healthcare to Delay Announcement of Second Quarter 2007 Earnings

Contact:
Melanie Gretzon
Director of Corporate Services
414-977-4000
[email protected]
or

Beth Frost-Johnson
Senior Vice President of Marketing
414-977-4254
[email protected]
both of Merge Healthcare

MILWAUKEE, Wis., Aug. 8 /PRNewswire-FirstCall/ — – Merge Technologies Incorporated, doing business as Merge Healthcare (Nasdaq: MRGE; TSX: MRG), a leading provider of medical imaging software and services, announces that it will not be issuing a press release today to report its financial results as of and for the three and six months ended June 30, 2007. This release was originally scheduled to be issued after today’s market close. Merge has also postponed its earnings conference call scheduled for Thursday, August 9, 2007 at 9:00 AM Central / 10:00 AM Eastern. Merge expects to hold such a call promptly after it reports second quarter results.

Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers’ productivity and enhance the quality of patient care they provide. For additional information, visit our website at http://www.mergehealthcare.com/.

Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company’s inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company’s inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.